Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker MDGL
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,077 | $430.9K | 10b5-1 | Nov 6, 2026 | Form 4 ↗ same day · 1,077 shares | Form 144 ↗ |
| Sep 28, 2026 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 50,000 | $25.8M | 10b5-1 | Sep 28, 2026 | — | Form 144 ↗ |
| Sep 11, 2026 | William Sibold Director, Officer | MDGL Madrigal Pharmaceuticals, Inc. | 5,221 | $2.8M | 10b5-1 | Sep 11, 2026 | Form 4 ↗ same day · 11,583 shares | Form 144 ↗ |
| Sep 9, 2026 | William John Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 6,362 | $3.4M | — | Sep 9, 2026 | Form 4 ↗ 2 days later · 11,583 shares | Form 144 ↗ |
| Aug 20, 2026 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 664 | $337.0K | — | Aug 17, 2026 | Form 4 ↗ 78 days later · 1,077 shares | Form 144 ↗ |
| Jul 20, 2026 | William Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,500 | $1.4M | — | Jul 20, 2026 | Form 4 ↗ same day · 2,500 shares | Form 144 ↗ |
| Jun 1, 2026 | David Soergel Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,042 | $518.2K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ same day · 1,042 shares | Form 144 ↗ |
| May 22, 2026 | Richard Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | 5,682 | $2.9M | 10b5-1 | May 22, 2026 | Form 4 ↗ same day · 5,682 shares | Form 144 ↗ |
| May 18, 2026 | David Soergel Officer | MDGL Madrigal Pharmaceuticals, Inc. | 844 | $442.0K | — | May 18, 2026 | Form 4 ↗ same day · 844 shares | Form 144 ↗ |
| Mar 6, 2026 | Mardi Dier Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,336 | $587.0K | 10b5-1 | Mar 6, 2026 | Form 4 ↗ same day · 1,982 shares | Form 144 ↗ |
| Mar 6, 2026 | Mardi Dier Officer | MDGL Madrigal Pharmaceuticals, Inc. | 646 | $283.8K | — | Mar 6, 2026 | Form 4 ↗ same day · 1,982 shares | Form 144 ↗ |
| Mar 6, 2026 | William Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 1,663 | $730.6K | — | Mar 6, 2026 | Form 4 ↗ same day · 1,663 shares | Form 144 ↗ |
| Mar 6, 2026 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 360 | $158.2K | — | Mar 6, 2026 | Form 4 ↗ same day · 360 shares | Form 144 ↗ |
| Mar 6, 2026 | Carole Huntsman Officer | MDGL Madrigal Pharmaceuticals, Inc. | 419 | $184.1K | — | Mar 6, 2026 | Form 4 ↗ same day · 419 shares | Form 144 ↗ |
| Mar 6, 2026 | Rebecca Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 491 | $215.7K | — | Mar 6, 2026 | Form 4 ↗ same day · 491 shares | Form 144 ↗ |
| Mar 2, 2026 | Mardi Dier Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,183 | $511.1K | — | Mar 2, 2026 | Form 4 ↗ same day · 1,183 shares | Form 144 ↗ |
| Jan 26, 2026 | Carole A Huntsman Officer | MDGL Madrigal Pharmaceuticals, Inc. | 570 | $273.9K | 10b5-1 | Jan 26, 2026 | Form 4 ↗ same day · 910 shares | Form 144 ↗ |
| Jan 26, 2026 | Carole Huntsman Officer | MDGL Madrigal Pharmaceuticals, Inc. | 340 | $163.4K | — | Jan 26, 2026 | Form 4 ↗ same day · 910 shares | Form 144 ↗ |
| Jan 26, 2026 | William Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 1,577 | $757.7K | — | Jan 26, 2026 | Form 4 ↗ same day · 1,577 shares | Form 144 ↗ |
| Jan 26, 2026 | Rebecca Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 647 | $310.9K | — | Jan 26, 2026 | Form 4 ↗ same day · 647 shares | Form 144 ↗ |
| Jan 20, 2026 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 429 | $215.2K | 10b5-1 | Jan 20, 2026 | Form 4 ↗ same day · 692 shares | Form 144 ↗ |
| Jan 20, 2026 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 263 | $131.9K | — | Jan 20, 2026 | Form 4 ↗ same day · 692 shares | Form 144 ↗ |
| Jan 20, 2026 | Rebecca Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,238 | $1.1M | — | Jan 20, 2026 | Form 4 ↗ same day · 2,238 shares | Form 144 ↗ |
| Jan 9, 2026 | Rebecca A Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 18,650 | $10.4M | 10b5-1 | Jan 9, 2026 | Form 4 ↗ 4 days later · 18,410 shares | Form 144 ↗ |
| Dec 10, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 49,600 | $27.5M | 10b5-1 | Dec 10, 2025 | Form 4 ↗ 2 days later · 24,800 shares | Form 144 ↗ |
| Dec 10, 2025 | Rebecca A Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 18,650 | $10.3M | 10b5-1 | Dec 10, 2025 | Form 4 ↗ 2 days later · 18,650 shares | Form 144 ↗ |
| Dec 4, 2025 | William John Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,400 | $1.4M | — | Dec 4, 2025 | Form 4 ↗ same day · 2,400 shares | Form 144 ↗ |
| Dec 2, 2025 | Mardi C Dier Officer | MDGL Madrigal Pharmaceuticals, Inc. | 4,173 | $2.4M | 10b5-1 | Dec 2, 2025 | Form 4 ↗ 1 day later · 4,173 shares | Form 144 ↗ |
| Nov 21, 2025 | Carole Huntsman Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,064 | $576.8K | 10b5-1 | Nov 21, 2025 | Form 4 ↗ same day · 1,958 shares | Form 144 ↗ |
| Nov 21, 2025 | Carole Huntsman Officer | MDGL Madrigal Pharmaceuticals, Inc. | 894 | $484.7K | 10b5-1 | Nov 21, 2025 | Form 4 ↗ same day · 1,958 shares | Form 144 ↗ |
| Nov 13, 2025 | Richard S Levy Director | MDGL Madrigal Pharmaceuticals, Inc. | 8,500 | $4.5M | 10b5-1 | Nov 13, 2025 | Form 4 ↗ 1 day later · 8,500 shares | Form 144 ↗ |
| Nov 5, 2025 | Kenneth M Bate Director | MDGL Madrigal Pharmaceuticals, Inc. | 16,575 | $8.0M | — | Nov 5, 2025 | Form 4 ↗ 2 days later · 16,575 shares | Form 144 ↗ |
| Sep 9, 2025 | William John Sibold Officer and Director | MDGL Madrigal Pharmaceuticals, Inc. | 7,279 | $3.3M | — | Sep 9, 2025 | Form 4 ↗ same day · 7,279 shares | Form 144 ↗ |
| Aug 29, 2025 | Fred Craves Former Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,900 | $1.3M | — | Aug 29, 2025 | — | Form 144 ↗ |
| Aug 21, 2025 | William Sibold Director, Officer | MDGL Madrigal Pharmaceuticals, Inc. | 7,616 | $3.0M | 10b5-1 | Aug 21, 2025 | Form 4 ↗ same day · 7,616 shares | Form 144 ↗ |
| Aug 20, 2025 | Fred Craves Former Director | MDGL Madrigal Pharmaceuticals, Inc. | 1,000 | $390.2K | — | Aug 20, 2025 | — | Form 144 ↗ |
| Aug 18, 2025 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 846 | $312.9K | 10b5-1 | Aug 18, 2025 | Form 4 ↗ same day · 1,304 shares | Form 144 ↗ |
| Aug 18, 2025 | Shannon Kelley Officer | MDGL Madrigal Pharmaceuticals, Inc. | 458 | $169.4K | 10b5-1 | Aug 18, 2025 | Form 4 ↗ same day · 1,304 shares | Form 144 ↗ |
| Aug 18, 2025 | Fred Craves Former Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,000 | $764.5K | — | Aug 18, 2025 | — | Form 144 ↗ |
| Aug 15, 2025 | Fred Craves Former Director | MDGL Madrigal Pharmaceuticals, Inc. | 4,100 | $1.5M | — | Aug 15, 2025 | — | Form 144 ↗ |
| Aug 15, 2025 | Kenneth M Bate Director | MDGL Madrigal Pharmaceuticals, Inc. | 10,000 | $3.7M | — | Aug 15, 2025 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Aug 13, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 129,172 | $46.4M | 10b5-1 | Aug 13, 2025 | Form 4 ↗ same day · 129,172 shares | Form 144 ↗ |
| Aug 12, 2025 | Rebecca Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 43,263 | $15.1M | 10b5-1 | Aug 12, 2025 | Form 4 ↗ 1 day later · 46,463 shares | Form 144 ↗ |
| Aug 12, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 43,605 | $15.2M | 10b5-1 | Aug 12, 2025 | Form 4 ↗ 1 day later · 46,808 shares | Form 144 ↗ |
| Aug 11, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 3,203 | $1.1M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 2 days later · 46,808 shares | Form 144 ↗ |
| Aug 11, 2025 | Rebecca Taub Director | MDGL Madrigal Pharmaceuticals, Inc. | 3,200 | $1.1M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 2 days later · 46,463 shares | Form 144 ↗ |
| Jul 18, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 1,400 | $488.2K | 10b5-1 | Jul 18, 2025 | Form 4 ↗ 4 days later · 1,400 shares | Form 144 ↗ |
| Jul 18, 2025 | Rebecca Taub Director, Officer | MDGL Madrigal Pharmaceuticals, Inc. | 1,000 | $348.7K | 10b5-1 | Jul 18, 2025 | Form 4 ↗ 4 days later · 1,000 shares | Form 144 ↗ |
| Jul 17, 2025 | Rebecca Taub Director, Officer | MDGL Madrigal Pharmaceuticals, Inc. | 2,657 | $916.6K | 10b5-1 | Jul 17, 2025 | Form 4 ↗ 1 day later · 29,101 shares | Form 144 ↗ |
| Jul 17, 2025 | Paul Friedman Director | MDGL Madrigal Pharmaceuticals, Inc. | 2,700 | $931.4K | 10b5-1 | Jul 17, 2025 | Form 4 ↗ 1 day later · 28,876 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances